Loading Events

MSE GRADUATE SEMINAR

Date: Thursday, March 12, 2020
Time: 12:00 p.m.
Location: RS211
Title: Drug Loaded Nanobubbles for Focused Ultrasound-Induced Cancer Therapy
Presenter: Yiran Zou (MASc Candidate)
Supervisor/s: Prof. Naomi Matsuura
 
ABSTRACT: Cancer is the leading cause of death in Canada. Chemotherapy is a commonly employed cancer treatment where toxic anti-cancer drugs are given to patients intravenously. However, this treatment is not yet optimal and common drawbacks reside in the limited drug accumulation in tumour and systemic drug circulation induced toxicity to healthy organs, leading to debilitating side effects. Blood vessels are essential for tumour growth and therefore are treated as therapeutic targets in cancer therapy, termed as antivascular therapy. One way to achieve this is via the mechanical disruption of the vessel wall using focused ultrasound stimulated bubble cavitation. Therefore, this study aims to use drug (DTX) loaded nanobubbles (NB) for combined ultrasound triggered drug delivery and antivascular therapy to achieve complementary effects for improved treatment outcomes. Compared to conventional chemotherapy, these NBs enable shielding of the drug payload before ultrasound exposure to reduce systemic toxicity and can deliver high dosage of DTX on tumour site after ultrasound stimulated cavitation. In this presentation, we will report a method of synthesizing drug-loaded nanobubbles, followed by its characterizations both in vitro and in vivo. In short, DTX-NBs are formed via a lyophilization-reconstitution method from its precursor oil droplets. 105.94 ± 21.03 micrograms of DTX was loaded onto 11.05 ± 0.13 billion bubbles containing 0.45 ± 0.03 microliter of gas per milliliter of DTX-NB suspension. DTX-NBs with a mode diameter at around 230 nm was measured and 99.5 ± 0.7 % of its population below 1 micron, demonstrating the population is within the nano-range with little batch to batch variance. At a previous reported safe gas dosage of ~ 9 microliter/kg, DTX-NB can achieve a dosage at ~ 2.12 mg/kg, comparable to that of the FDA approved clinical dosage of Taxotere®. At 200 nM, the cytotoxicity of DTX-NBs after cavitation was equivalent to that of Taxotere® (*p

MSE GRADUATE SEMINAR

Event Details

Venue

March 12, 2020 @ 12:00 pm - 1:00 pm

Date: Thursday, March 12, 2020
Time: 12:00 p.m.
Location: RS211
Title: Drug Loaded Nanobubbles for Focused Ultrasound-Induced Cancer Therapy
Presenter: Yiran Zou (MASc Candidate)
Supervisor/s: Prof. Naomi Matsuura
 
ABSTRACT: Cancer is the leading cause of death in Canada. Chemotherapy is a commonly employed cancer treatment where toxic anti-cancer drugs are given to patients intravenously. However, this treatment is not yet optimal and common drawbacks reside in the limited drug accumulation in tumour and systemic drug circulation induced toxicity to healthy organs, leading to debilitating side effects. Blood vessels are essential for tumour growth and therefore are treated as therapeutic targets in cancer therapy, termed as antivascular therapy. One way to achieve this is via the mechanical disruption of the vessel wall using focused ultrasound stimulated bubble cavitation. Therefore, this study aims to use drug (DTX) loaded nanobubbles (NB) for combined ultrasound triggered drug delivery and antivascular therapy to achieve complementary effects for improved treatment outcomes. Compared to conventional chemotherapy, these NBs enable shielding of the drug payload before ultrasound exposure to reduce systemic toxicity and can deliver high dosage of DTX on tumour site after ultrasound stimulated cavitation. In this presentation, we will report a method of synthesizing drug-loaded nanobubbles, followed by its characterizations both in vitro and in vivo. In short, DTX-NBs are formed via a lyophilization-reconstitution method from its precursor oil droplets. 105.94 ± 21.03 micrograms of DTX was loaded onto 11.05 ± 0.13 billion bubbles containing 0.45 ± 0.03 microliter of gas per milliliter of DTX-NB suspension. DTX-NBs with a mode diameter at around 230 nm was measured and 99.5 ± 0.7 % of its population below 1 micron, demonstrating the population is within the nano-range with little batch to batch variance. At a previous reported safe gas dosage of ~ 9 microliter/kg, DTX-NB can achieve a dosage at ~ 2.12 mg/kg, comparable to that of the FDA approved clinical dosage of Taxotere®. At 200 nM, the cytotoxicity of DTX-NBs after cavitation was equivalent to that of Taxotere® (*p

Details

Date:
March 12, 2020
Time:
12:00 pm - 1:00 pm
Website:
https://mse.utoronto.ca/event/mse-graduate-seminar/

Upcoming Events

All
  • All
  • Alumni events
  • Anti-Racism and Cultural Diversity Office events
  • Convocation events
  • Faculty & staff events
  • Holidays
  • Info sessions
  • Lectures, seminars and workshops
  • Socials
  • U of T holidays & closures

2025 Toronto Robotics Conference

Tue July 15, 2025 @ 9:00 am - Wed July 16, 2025 @ 4:00 pm
Join the University of Toronto Robotics Institute’s expert network at the University of Toronto Mississauga on July 15 and 16 for a two-day, dual-track showcase of the latest AI-robotics research...

U of T Alumni x Featherstone Estate Winery Event

Thu July 17, 2025 @ 5:00 pm - 9:00 pm
  Located in the beautiful setting of Niagara wine country, Featherstone Estate Winery—owned by close friends of the university Rayla and George Myhal (U of T Engineering)—will open its doors for an unforgettable alumni celebration.  ...

Taipei, TW: Alumni & Friends Summer Gathering

Sun July 20, 2025 @ 3:00 pm - 5:00 pm
Attention U of T Engineering alumni in Taipei! Join U of T alumni, family and friends for an afternoon of socializing and networking. Whether you are a recent grad or an established...

Presidential Day

Fri August 1, 2025
The university will be closed.